Literature DB >> 29087626

Identification of risk factors for sessile and traditional serrated adenomas of the colon by using big data analysis.

Jeung Hui Pyo1, Sang Yun Ha2, Sung Noh Hong3, Dong Kyung Chang3, Hee Jung Son1,3, Kyoung-Mee Kim2, Hyeseung Kim4, Kyunga Kim4, Jee Eun Kim1, Yoon-Ho Choi1,3, Young-Ho Kim3.   

Abstract

BACKGROUND AND AIM: Little is known about the risk factors associated with serrated polyps, because the early studies, which occurred before the new World Health Organization classification was introduced, included mixtures of serrated polyps. This study aimed to evaluate the risk factors associated with the presence of sessile serrated adenomas (SSAs) and traditional serrated adenomas (TSAs) using big data analytics.
METHODS: Using a case-control design, we evaluated the risk factors associated with the presence of SSAs and TSAs. Subjects who underwent colonoscopies from 2002 to 2012 as part of the comprehensive health screening programs undertaken at the Samsung Medical Center, Korea, participated in this study.
RESULTS: Of the 48 677 individuals who underwent colonoscopies, 183 (0.4%) had SSAs and 212 (0.4%) had TSAs. The multivariate analysis determined that being aged ≥ 50 years (odds ratio [OR] 1.91, 95% confidential interval [CI] 1.27-2.90, P = 0.002) and a history of colorectal cancer among first-degree relatives (OR 3.14, 95% CI 1.57-6.27, P = 0.001) were significant risk factors associated with the presence of SSAs and that being aged ≥ 50 years (OR 2.61, 95% CI 1.79-3.80, P < 0.001), obesity (OR 1.63, 95% CI 1.12-2.36, P = 0.010), and a higher triglyceride level (OR 1.63, 95% CI 1.12-2.36, P = 0.010) were independent risk factors associated with the presence of TSAs.
CONCLUSIONS: We used big data analytics to determine the risk factors associated with the presence of specific polyp subgroups, and individuals who have these risk factors should be carefully scrutinized for the presence of SSAs or TSAs during screening colonoscopies.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  big data; risk factors; sessile serrated adenoma; traditional serrated adenoma

Mesh:

Substances:

Year:  2018        PMID: 29087626     DOI: 10.1111/jgh.14035

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Polyp Detection Rate as a Surrogate for Adenoma and Sessile Serrated Adenoma/Polyp Detection Rates.

Authors:  Leonardo Zorron Cheng Tao Pu; Gurfarmaan Singh; Khizar Rana; Masanao Nakamura; Takeshi Yamamura; Sudarshan Krishnamurthi; Amanda Ovenden; Suzanne Edwards; Andrew Ruszkiewicz; Yoshiki Hirooka; Mitsuhiro Fujishiro; Alastair D Burt; Rajvinder Singh
Journal:  Gastrointest Tumors       Date:  2020-02-11

2.  Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps.

Authors:  Celina N Santiago; Samara Rifkin; Julia Drewes; Gerard Mullin; Emma Spence; Linda M Hylind; Joell J Gills; David Kafonek; David M Cromwell; Louis La Luna; Francis Giardello; Cynthia L Sears
Journal:  Cancer Prev Res (Phila)       Date:  2021-05-04

3.  Colorectal sessile serrated lesion with large size or synchronous neoplasm: a prospective study.

Authors:  Laxmi B Chavali; Kun Hu; Anish Sheth; Nan Gao; Wei Xiong; Lanjing Zhang
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-02       Impact factor: 2.586

Review 4.  Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden.

Authors:  Jennifer M Kolb; Christine L Molmenti; Swati G Patel; David A Lieberman; Dennis J Ahnen
Journal:  Am J Gastroenterol       Date:  2020-07       Impact factor: 12.045

5.  Rate of detection of serrated lesions at colonoscopy in an average-risk population: a meta-analysis of 129,001 individuals.

Authors:  Junjie Huang; Paul S F Chan; Tiffany W Y Pang; Peter Choi; Xiao Chen; Veeleah Lok; Zhi-Jie Zheng; Martin C S Wong
Journal:  Endosc Int Open       Date:  2021-02-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.